It has Hydrafacial signature and BB glow microneedling and some effect of whitening mesotherapy
10.1016/j.intimp.2021.108364 79 SadakaneC.WatanabeJ.FukutakeM.NisimuraH.MaemuraK.KaseY.et al (2015)
If you have malabsorption, are on dialysis, receive nutrition through a vein, or have thyroid disease, the answer may be different, but it should come from the doctor who knows your case
"We are pleased to see that our latest incretin medicine meets our expectations for safety and tolerability, glucose control and weight loss, and we look forward to additional data readouts later this year" Over 65 percent of participants given the highest orforglipron dose attained an A1C level less than or equal to 6.5 percent
Eaton, J
32 The primary outcome for the trial was the first occurrence of a major adverse cardiovascular event (death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke)